PMP Series: PMP Tools to Improve Controlled Substance Prescribing
A tour of the many tools to assist prescribers with evaluating the risks and benefits of controlled substance prescribing, particularly those to assess for higher-risk prescribing practices.
Objectives
- Review multiple tools available to the prescriber in the PMP
- Investigate the requirement to check the PMP and its application
- Evaluate peer group comparisons and higher-risk prescribing metrics
Audience
Prescribing clinicians and their teams
Continuing Medical Education
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Maine Medical Education Trust and CCSME. The Maine Medical Education Trust is accredited by the Maine Medical Association Committee on Continuing Medical Education and Accreditation to provide continuing medical education for physicians.
This activity qualifies for 1 credit of the 3 CME credit requirement for opioid medication education found in P.L. 2015, Chapter 488, Maine’s legislation to address the opioid drug crisis.
The Maine Medical Education Trust designates this regularly scheduled series for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
*Nurses and Nurse Practitioners will be awarded a certificate of participation with a maximum of 1 AMA PRA Category 1 Credit™.
Contact Hours
1 contact hour for social workers, licensed clinical professional counselors, and behavioral health professionals.
Speaker
-
Elisabeth Fowlie MockMDDr. Mock received her doctorate from Vanderbilt Medical School and a Master of Public Health in Health Policy and Administration from UNC-Chapel Hill. She also attended Colby College and Emory University. She is Board Certified in Family Medicine and Addiction Medicine. She works primarily as a clinical educator and consultant with per diem hospitalist and buprenorphine clinic shifts and is Maine PMP Clinical and Policy Advisor for Maine’s Office of Behavioral Health.
